Literature DB >> 18818212

Impact of advanced age on survival in patients with implantable cardioverter defibrillators.

Cara N Pellegrini1, Keane Lee, Jeffrey E Olgin, Mintu P Turakhia, Zian H Tseng, Randall Lee, Nitish Badhwar, Byron Lee, Paul D Varosy.   

Abstract

AIMS: Given the selectivity of clinical trial patients and meager representation of elderly in the major implantable cardioverter defibrillator (ICD) randomized trials (<25%), whether such data apply to elderly patients overall is unclear. The purpose of our study is to understand the influence of age on mortality after ICD implantation. METHODS AND
RESULTS: We performed a retrospective cohort study of 502 consecutive patients receiving ICDs from 1993 to 2003 at a single university hospital. The primary predictor was patient age, categorized as <65, 65-75, and >75 years at ICD implantation. The primary outcome was time to death. Mean follow-up was 4 years. Median survival after ICD implantation was 5.3 years among subjects >75 years, less than half that of the youngest group. After adjusting for potential confounders, compared with subjects <65 years of age, patients >75 years [hazard ratio (HR), 4.7; 95% confidence interval (CI), 2.8-7.9; P < 0.001] and those 65-75 years (HR, 2.8; 95% CI, 1.7-4.8; P < 0.001) were at greater risk of death. Increased age was associated with higher total, cardiac, and non-cardiac mortality (all P <or= 0.001).
CONCLUSION: Age at ICD implantation is strongly and independently associated with mortality. Age should be considered among potential co-morbidities in anticipating survival of the elderly patient prior to ICD implantation.

Entities:  

Mesh:

Year:  2008        PMID: 18818212      PMCID: PMC2721725          DOI: 10.1093/europace/eun253

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  26 in total

1.  Do baseline characteristics accurately discriminate between patients likely versus unlikely to benefit from implantable defibrillator therapy? Evaluation of the Canadian implantable defibrillator study implantable cardioverter defibrillatory efficacy score in the antiarrhythmics versus implantable defibrillators trial.

Authors:  D V Exner; R S Sheldon; S L Pinski; J Kron; A Hallstrom
Journal:  Am Heart J       Date:  2001-01       Impact factor: 4.749

2.  Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH).

Authors:  K H Kuck; R Cappato; J Siebels; R Rüppel
Journal:  Circulation       Date:  2000-08-15       Impact factor: 29.690

Review 3.  Willingness to pay for a quality-adjusted life year: in search of a standard.

Authors:  R A Hirth; M E Chernew; E Miller; A M Fendrick; W G Weissert
Journal:  Med Decis Making       Date:  2000 Jul-Sep       Impact factor: 2.583

4.  How often do sensitivity analyses for economic parameters change cost-utility analysis conclusions?

Authors:  Bruce R Schackman; Heather Taffet Gold; Patricia W Stone; Peter J Neumann
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

5.  Efficacy of the implantable cardioverter-defibrillator in the elderly.

Authors:  P T Panotopoulos; K Axtell; A J Anderson; J Sra; Z Blanck; S Deshpande; M Biehl; E T Keelan; M R Jazayeri; M Akhtar; A Dhala
Journal:  J Am Coll Cardiol       Date:  1997-03-01       Impact factor: 24.094

6.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

Authors:  Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews
Journal:  N Engl J Med       Date:  2002-03-19       Impact factor: 91.245

7.  Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators.

Authors:  A J Moss; W J Hall; D S Cannom; J P Daubert; S L Higgins; H Klein; J H Levine; S Saksena; A L Waldo; D Wilber; M W Brown; M Heo
Journal:  N Engl J Med       Date:  1996-12-26       Impact factor: 91.245

8.  A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators.

Authors:  A E Buxton; K L Lee; J D Fisher; M E Josephson; E N Prystowsky; G Hafley
Journal:  N Engl J Med       Date:  1999-12-16       Impact factor: 91.245

9.  Outcomes and costs of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death among the elderly.

Authors:  Peter W Groeneveld; Steven A Farmer; Janice J Suh; Mary Anne Matta; Feifei Yang
Journal:  Heart Rhythm       Date:  2008-01-29       Impact factor: 6.343

10.  Shock occurrence and survival in 241 patients with implantable cardioverter-defibrillator therapy.

Authors:  W Grimm; B T Flores; F E Marchlinski
Journal:  Circulation       Date:  1993-06       Impact factor: 29.690

View more
  9 in total

1.  Bundle-branch block morphology and other predictors of outcome after cardiac resynchronization therapy in Medicare patients.

Authors:  Kenneth C Bilchick; Sandeep Kamath; John P DiMarco; George J Stukenborg
Journal:  Circulation       Date:  2010-11-01       Impact factor: 29.690

2.  Elevated γ-glutamyltransferase in implantable cardioverter defibrillator patients.

Authors:  Wolfgang Dichtl; Thomas Wolber; Ursula Paoli; Thomas Theurl; Simon Brüllmann; Markus Stühlinger; Thomas Berger; Karin Spuller; Alexander Strasak; Otmar Pachinger; Laurent Haegeli; Firat Duru; Florian Hintringer
Journal:  Wien Klin Wochenschr       Date:  2011-09-02       Impact factor: 1.704

3.  Cardiac care for older adults. Time for a new paradigm.

Authors:  Daniel E Forman; Michael W Rich; Karen P Alexander; Susan Zieman; Mathew S Maurer; Samer S Najjar; Joseph C Cleveland; Harlan M Krumholz; Nanette K Wenger
Journal:  J Am Coll Cardiol       Date:  2011-05-03       Impact factor: 24.094

Review 4.  Causes and prevention of sudden cardiac death in the elderly.

Authors:  Patricia Tung; Christine M Albert
Journal:  Nat Rev Cardiol       Date:  2013-01-29       Impact factor: 32.419

5.  Health care utilisation after defibrillator implantation for primary prevention according to the guidelines in 2 Dutch academic medical centres.

Authors:  T Smith; P F van Dessel; D A M J Theuns; A Muskens-Heemskerk; R T van Domburg; A A Wilde; L Jordaens
Journal:  Neth Heart J       Date:  2011-10       Impact factor: 2.380

Review 6.  Guidance on reuse of cardio-vascular catheters and devices in India: A consensus document.

Authors:  Aditya Kapoor; Amit Vora; Gita Nataraj; Sundeep Mishra; Prafulla Kerkar; C N Manjunath
Journal:  Indian Heart J       Date:  2017-04-13

7.  Primary results from the Japanese Heart Failure and Sudden Cardiac Death Prevention Trial (HINODE).

Authors:  Kazutaka Aonuma; Kenji Ando; Kengo Kusano; Toru Asai; Koichi Inoue; Yukihiro Inamura; Takanori Ikeda; Takeshi Mitsuhashi; Toyoaki Murohara; Nobuhiro Nishii; Akihiko Nogami; Wataru Shimizu; Caroline Beaudoint; Torri Simon; Torsten Kayser; Hussin Azlan; Ngarmukos Tachapong; Joseph Yat-Sun Chan; Valentina Kutyifa; Yasushi Sakata
Journal:  ESC Heart Fail       Date:  2022-04-01

8.  Usefulness of the MADIT-ICD Benefit Score in a Large Mixed Patient Cohort of Primary Prevention of Sudden Cardiac Death.

Authors:  Kevin Willy; Julia Köbe; Florian Reinke; Benjamin Rath; Christian Ellermann; Julian Wolfes; Felix K Wegner; Patrick R Leitz; Philipp S Lange; Lars Eckardt; Gerrit Frommeyer
Journal:  J Pers Med       Date:  2022-07-28

9.  Comparison of pharmacological treatment alone vs. treatment combined with implantable cardioverter defibrillator therapy in patients older than 75 years.

Authors:  Marcelino Cortés; Julia Anna Palfy; Marta Lopez; Juan Martínez; Ana Lucia Rivero; Ana Devesa; Juan Antonio Franco-Peláez; Sem Briongos; Mikel Taibo-Urquia; Juan Benezet; Jose-Manuel Rubio
Journal:  ESC Heart Fail       Date:  2018-06-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.